UTA CP2 NURS 5338 - FINAL EXAM
REVIEW EXAM QUESTIONS AND
ANSWERS GRADED A+ 2026
Postprandial Glucose - ANS The blood sugar level measured after eating, which can indicate
how well the body manages glucose after meals.
Hemoglobin A1C - ANS A blood test that measures the average blood sugar levels over the
past two to three months, used to diagnose and monitor diabetes.
Lantus Insulin - ANS A long-acting insulin used to help control blood sugar levels in people
with diabetes.
Carbohydrate Counting - ANS A method of tracking carbohydrate intake to manage blood
sugar levels, particularly important for people with diabetes.
Somogyi Effect - ANS A phenomenon where low blood sugar during the night causes a
rebound increase in blood sugar levels in the morning.
Dawn Phenomenon - ANS A natural increase in blood sugar levels in the early morning due to
hormonal changes, not related to previous low blood sugar.
@COPYRIGHT 2026/2027 ALL RIGHTS RESERVED
1
, Rebound Hyperglycemia - ANS A term often used to describe the increase in blood sugar that
follows a hypoglycemic episode.
Continuous Glucose Monitoring (CGM) - ANS A method of tracking blood sugar levels
continuously throughout the day and night, providing real-time data.
Otitis Externa - ANS An infection of the outer ear canal, often associated with water
exposure, particularly common in summer.
Heatstroke - ANS A severe condition resulting from prolonged exposure to high
temperatures, leading to a failure of the body's temperature regulation.
ASCVD Risk Estimator - ANS A tool used to estimate the 10-year risk of atherosclerotic
cardiovascular disease, aiding in treatment decisions.
Statin Therapy - ANS Medications used to lower cholesterol levels in the blood, particularly
effective in reducing cardiovascular risk.
Moderate-Intensity Statins - ANS Statins that lower LDL cholesterol by 30-49%,
recommended for patients with diabetes aged 40-75 years.
High-Intensity Statins - ANS Statins that lower LDL cholesterol by 50% or more,
recommended for patients with diabetes at higher cardiovascular risk.
Insulin Resistance - ANS A condition where the body's cells become less responsive to insulin,
often leading to higher blood sugar levels.
@COPYRIGHT 2026/2027 ALL RIGHTS RESERVED
2
REVIEW EXAM QUESTIONS AND
ANSWERS GRADED A+ 2026
Postprandial Glucose - ANS The blood sugar level measured after eating, which can indicate
how well the body manages glucose after meals.
Hemoglobin A1C - ANS A blood test that measures the average blood sugar levels over the
past two to three months, used to diagnose and monitor diabetes.
Lantus Insulin - ANS A long-acting insulin used to help control blood sugar levels in people
with diabetes.
Carbohydrate Counting - ANS A method of tracking carbohydrate intake to manage blood
sugar levels, particularly important for people with diabetes.
Somogyi Effect - ANS A phenomenon where low blood sugar during the night causes a
rebound increase in blood sugar levels in the morning.
Dawn Phenomenon - ANS A natural increase in blood sugar levels in the early morning due to
hormonal changes, not related to previous low blood sugar.
@COPYRIGHT 2026/2027 ALL RIGHTS RESERVED
1
, Rebound Hyperglycemia - ANS A term often used to describe the increase in blood sugar that
follows a hypoglycemic episode.
Continuous Glucose Monitoring (CGM) - ANS A method of tracking blood sugar levels
continuously throughout the day and night, providing real-time data.
Otitis Externa - ANS An infection of the outer ear canal, often associated with water
exposure, particularly common in summer.
Heatstroke - ANS A severe condition resulting from prolonged exposure to high
temperatures, leading to a failure of the body's temperature regulation.
ASCVD Risk Estimator - ANS A tool used to estimate the 10-year risk of atherosclerotic
cardiovascular disease, aiding in treatment decisions.
Statin Therapy - ANS Medications used to lower cholesterol levels in the blood, particularly
effective in reducing cardiovascular risk.
Moderate-Intensity Statins - ANS Statins that lower LDL cholesterol by 30-49%,
recommended for patients with diabetes aged 40-75 years.
High-Intensity Statins - ANS Statins that lower LDL cholesterol by 50% or more,
recommended for patients with diabetes at higher cardiovascular risk.
Insulin Resistance - ANS A condition where the body's cells become less responsive to insulin,
often leading to higher blood sugar levels.
@COPYRIGHT 2026/2027 ALL RIGHTS RESERVED
2
